Ofatumumab | m-entrepreneurship.com

Product Name :
Ofatumumab

Search keywords :
Ofatumumab

drugId :
null

Target Vo:
B-lymphocyte antigen CD20

Target Vo Short Name :
CD20

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :
United States

First Approval Date Filter:
2009

Origin Company_Name :
Genmab A/S

Active Company_Name :
Beijing Novartis Pharma Co Ltd

Active Indication_Name:
Multiple Sclerosis, Relapsing-Remitting

In Active Indication_Name:
Lymphoma, Non-Hodgkin

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Retinoic Acid Receptor alpha Rabbit mAb Purity
Rilotumumab Cancer
PKR Antibody: PKR Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to PKR. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts